CN Patent

CN114057758A — 补体因子b抑制剂及其药物组合物、制备方法和用途

Assigned to Wuhan LL Science and Technology Development Co Ltd · Expires 2022-02-18 · 4y expired

What this patent protects

本发明提供了一类式(I)所示的含哌啶的杂环类化合物，该类化合物通过抑制/调节补体因子B来治疗患有与补体旁路途径活化有关的病症和疾病、例如阵发性睡眠性血红蛋白尿症(PNH)、IgA肾病(IgAN)、包括C3肾小球病(C3G)和膜型肾病(MN)等多种肾小球类疾病、非典型溶血尿毒综合征(aHUS)、年龄相关性黄斑变性(AMD)、糖尿病性视网膜病变(DR)和其它与补体旁路途径异常激活相关的疾病。

USPTO Abstract

本发明提供了一类式(I)所示的含哌啶的杂环类化合物，该类化合物通过抑制/调节补体因子B来治疗患有与补体旁路途径活化有关的病症和疾病、例如阵发性睡眠性血红蛋白尿症(PNH)、IgA肾病(IgAN)、包括C3肾小球病(C3G)和膜型肾病(MN)等多种肾小球类疾病、非典型溶血尿毒综合征(aHUS)、年龄相关性黄斑变性(AMD)、糖尿病性视网膜病变(DR)和其它与补体旁路途径异常激活相关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN114057758A
Jurisdiction
CN
Classification
—
Expires
2022-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan LL Science and Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.